Fisker (NYSE:FSR) – The American electric vehicle manufacturer filed for bankruptcy last night, aiming...
CAPVAXIVE (V116) is specifically designed for adults and covers serotypes responsible for approximately 84% of invasive pneumococcal disease in...
KEYTRUDA is now the first and only anti-PD-1 therapy FDA-approved in combination with chemotherapy for adult patients with primary advanced or...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.